Long-term Outcome of Zonal Outer Retinopathy in Punctate Inner Choroidopathy or Multifocal Choroiditis

Changhua Christian Medical Foundation

Status: Completed

Conditions: Punctate Inner Choroidopathy

Treatments: Drug: Bevacizumab

Study type: Observational

Funder types: Other

Identifiers

NCT03897192

190318

Details and patient eligibility

About

To report the long term prognosis in patients with punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) and associated zonal outer retinopathy (ZOR).

Enrollment: 14 patients

Sex: All

Ages: 20 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) and associated zonal outer retinopathy (ZOR).
• Follow up over 4 years.

Exclusion criteria

• Patients with punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) without zonal outer retinopathy (ZOR).